Annovis Bio, Inc. (ANVS)
NYSE: ANVS · Real-Time Price · USD
1.500
-0.150 (-9.09%)
Mar 31, 2025, 4:00 PM EDT - Market closed
Annovis Bio Market Cap
Annovis Bio has a market cap or net worth of $29.23 million as of March 31, 2025. Its market cap has decreased by -69.03% in one year.
Market Cap
29.23M
Enterprise Value
18.68M
1-Year Change
-69.03%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since January 29, 2020, Annovis Bio's market cap has decreased from $62.51M to $29.23M, a decrease of -53.24%. That is a compound annual growth rate of -13.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 29.23M | -57.88% |
| Dec 31, 2024 | 69.40M | -63.84% |
| Dec 29, 2023 | 191.90M | 75.03% |
| Dec 30, 2022 | 109.64M | -23.01% |
| Dec 31, 2021 | 142.41M | 174.06% |
| Dec 31, 2020 | 51.96M | -16.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |